- Home
- CLST vs CLNN Comparison
CLST vs CLNN Comparison
Compare CLST & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- CLNN
- Stock Information
- Founded
- CLST 1922
- CLNN 2012
- Country
- CLST United States
- CLNN United States
- Employees
- CLST N/A
- CLNN N/A
- Industry
- CLST
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- CLST
- CLNN Health Care
- Exchange
- CLST Nasdaq
- CLNN Nasdaq
- Market Cap
- CLST 50.2M
- CLNN 43.0M
- IPO Year
- CLST N/A
- CLNN N/A
- Fundamental
- Price
- CLST $11.63
- CLNN $4.02
- Analyst Decision
- CLST
- CLNN Strong Buy
- Analyst Count
- CLST 0
- CLNN 4
- Target Price
- CLST N/A
- CLNN $59.25
- AVG Volume (30 Days)
- CLST 7.3K
- CLNN 60.5K
- Earning Date
- CLST 10-24-2024
- CLNN 11-13-2024
- Dividend Yield
- CLST N/A
- CLNN N/A
- EPS Growth
- CLST N/A
- CLNN N/A
- EPS
- CLST N/A
- CLNN N/A
- Revenue
- CLST $4,949,000.00
- CLNN $421,000.00
- Revenue This Year
- CLST N/A
- CLNN N/A
- Revenue Next Year
- CLST N/A
- CLNN $1,058.37
- P/E Ratio
- CLST N/A
- CLNN N/A
- Revenue Growth
- CLST N/A
- CLNN N/A
- 52 Week Low
- CLST $10.60
- CLNN $3.82
- 52 Week High
- CLST $12.10
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- CLST 55.75
- CLNN 32.84
- Support Level
- CLST $11.41
- CLNN $3.88
- Resistance Level
- CLST $11.70
- CLNN $4.78
- Average True Range (ATR)
- CLST 0.09
- CLNN 0.48
- MACD
- CLST 0.00
- CLNN -0.17
- Stochastic Oscillator
- CLST 69.44
- CLNN 9.26
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).